Net Cash Provided by (Used in) Operating Activities |
-108K |
USD |
-42.4% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
107K |
USD |
+63.4% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
35B |
shares |
+250% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
9.44B |
shares |
+1127% |
Q1 2024 |
FY 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
260 |
USD |
+4% |
Q2 2024 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
-100% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
4.88M |
USD |
+7.16% |
Q1 2024 |
FY 2024 |
Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Property, Plant and Equipment, Gross |
1.25M |
USD |
0% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
4.88M |
USD |
+7.16% |
Q1 2024 |
FY 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Additional Paid in Capital |
67.4M |
USD |
+2.08% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2024 |
FY 2024 |
Interest Expense |
332K |
USD |
+22.4% |
Q2 2024 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
FY 2024 |